Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation

Published:2017-08-25 Issue:8 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Peinemann Frank¹,van Dalen Elvira C²,Enk Heike³,Berthold Frank¹

Affiliation:

1. Children's Hospital, University of Cologne; Pediatric Oncology and Hematology; Kerpener Str. 62 Cologne Germany 50937

2. Emma Children's Hospital/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 (room H4-139) Amsterdam Netherlands 1100 DD

3. c/o Cochrane Childhood Cancer; Amsterdam Netherlands

Publisher

Wiley

Subject

Pharmacology (medical)

Reference142 articles.

1. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study;Haas-Kogan;International Journal of Radiation Oncology Biology Physics,2003

2. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A Children's Cancer Group study;Maris;Journal of Clinical Oncology,2000

3. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study;Matthay;Journal of Clinical Oncology,2009

4. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;New England Journal of Medicine,1999

5. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group;Park;Pediatric Blood and Cancer,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial to Mesenchymal Transition in Neuroblastoma: Mechanisms and Therapeutic Considerations;Current Tissue Microenvironment Reports;2024-07-15

2. CLMP is a tumor suppressor that determines all-trans retinoic acid response in colorectal cancer;Developmental Cell;2023-12

3. Reduced Anticancer Potency of Carboplatin in the Presence of Sialic Acid in SH-SY5Y Cells;Jentashapir Journal of Cellular and Molecular Biology;2023-11-01

4. Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells;Clinical Epigenetics;2023-10-19

5. Palbociclib releases the latent differentiation capacity of neuroblastoma cells;Developmental Cell;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3